Advances and Opportunities to Address Co-Infections:

CMV Retinitis and Hepatitis CIAS 2013

Sunday 30 July

Why Co-Infections…?Co-infections remain important despite the success

of ART roll outLate presenters - CMV Important co-infection even in face of ART - HCV

Need for additional political will and fundingTesting and treatment often not supportedFew guidelinesRegional importance

Key opportunitiesCMV: Potential for decentralization of screening,

diagnosis and treatmentHCV: Potential for paradigm shifting pipeline regimens

Goals: CMV and HCVExamine burden

Explore challenges in diagnosis and treatment

Share MSF experience

Highlight critical and timely opportunities to improve access to diagnosis, treatment and care

AgendaCMV Retinitis – the neglected co-infection

Khin Nyein Chan, Nathan Ford Peter Saranchuk Arax Bozadjian

**Respondant: Dr. Rewari

Hepatitis C – Increasing recognition of importance Nicolas Durier Isabelle Andrieux-Meyer Manica Balasegaram

**Respondant: Shiba Phurailatpam